New Genetic Engineering – Small Cause, Big Effect
By Benedikt Haerlin,
ARC2020
| 07. 07. 2023
Adding, removing or swapping individual base pairs in the genome can make a huge difference to the functioning of a cell and the properties of an entire organism. It’s a bit like Johann Sebastian Bach’s definition of skilful piano playing: you just have to press the right key at the right time. It’s that simple, and yet also that difficult. Therein lies the appeal of genetic engineering, but also its risk.
The European Commission is now proposing that plants that have been genetically modified at up to twenty different sites of the genome should nevertheless be “considered equivalent to conventional plants”. At these twenty sites, any number of base pairs (nucleotides) may be deleted or inverted, up to 20 base pairs may be completely altered or replaced, any length of contigous DNA sequences may be replaced by related sequences, and any other alteration of any kind may be made that already occurs in any plant that can be crossed directly with the genetically modified plant or via intermediate steps.
No individual risk assessment and approval would be required for those...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...